149 related articles for article (PubMed ID: 35812313)
1. Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Schillemans T; Tragante V; Maitusong B; Gigante B; Cresci S; Laguzzi F; Vikström M; Richards M; Pilbrow A; Cameron V; Foco L; Doughty RN; Kuukasjärvi P; Allayee H; Hartiala JA; Tang WHW; Lyytikäinen LP; Nikus K; Laurikka JO; Srinivasan S; Mordi IR; Trompet S; Kraaijeveld A; van Setten J; Gijsberts CM; Maitland-van der Zee AH; Saely CH; Gong Y; Johnson JA; Cooper-DeHoff RM; Pepine CJ; Casu G; Leiherer A; Drexel H; Horne BD; van der Laan SW; Marziliano N; Hazen SL; Sinisalo J; Kähönen M; Lehtimäki T; Lang CC; Burkhardt R; Scholz M; Jukema JW; Eriksson N; Åkerblom A; James S; Held C; Hagström E; Spertus JA; Algra A; de Faire U; Åkesson A; Asselbergs FW; Patel RS; Leander K
Front Physiol; 2022; 13():909870. PubMed ID: 35812313
[No Abstract] [Full Text] [Related]
2. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.
Mahmoodi BK; Tragante V; Kleber ME; Holmes MV; Schmidt AF; McCubrey RO; Howe LJ; Direk K; Allayee H; Baranova EV; Braund PS; Delgado GE; Eriksson N; Gijsberts CM; Gong Y; Hartiala J; Heydarpour M; Pasterkamp G; Kotti S; Kuukasjärvi P; Lenzini PA; Levin D; Lyytikäinen LP; Muehlschlegel JD; Nelson CP; Nikus K; Pilbrow AP; Wilson Tang WH; van der Laan SW; van Setten J; Vilmundarson RO; Deanfield J; Deloukas P; Dudbridge F; James S; Mordi IR; Teren A; Bergmeijer TO; Body SC; Bots M; Burkhardt R; Cooper-DeHoff RM; Cresci S; Danchin N; Doughty RN; Grobbee DE; Hagström E; Hazen SL; Held C; Hoefer IE; Hovingh GK; Johnson JA; Kaczor MP; Kähönen M; Klungel OH; Laurikka JO; Lehtimäki T; Maitland-van der Zee AH; McPherson R; Palmer CN; Kraaijeveld AO; Pepine CJ; Sanak M; Sattar N; Scholz M; Simon T; Spertus JA; Stewart AFR; Szczeklik W; Thiery J; Visseren FLJ; Waltenberger J; Richards AM; Lang CC; Cameron VA; Åkerblom A; Pare G; März W; Samani NJ; Hingorani AD; Ten Berg JM; Wallentin L; Asselbergs FW; Patel RS
Circulation; 2020 Aug; 142(6):546-555. PubMed ID: 32654539
[TBL] [Abstract][Full Text] [Related]
3. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.
Patel RS; Schmidt AF; Tragante V; McCubrey RO; Holmes MV; Howe LJ; Direk K; Åkerblom A; Leander K; Virani SS; Kaminski KA; Muehlschlegel JD; Dubé MP; Allayee H; Almgren P; Alver M; Baranova EV; Behlouli H; Boeckx B; Braund PS; Breitling LP; Delgado G; Duarte NE; Dufresne L; Eriksson N; Foco L; Gijsberts CM; Gong Y; Hartiala J; Heydarpour M; Hubacek JA; Kleber M; Kofink D; Kuukasjärvi P; Lee VV; Leiherer A; Lenzini PA; Levin D; Lyytikäinen LP; Martinelli N; Mons U; Nelson CP; Nikus K; Pilbrow AP; Ploski R; Sun YV; Tanck MWT; Tang WHW; Trompet S; van der Laan SW; van Setten J; Vilmundarson RO; Viviani Anselmi C; Vlachopoulou E; Boerwinkle E; Briguori C; Carlquist JF; Carruthers KF; Casu G; Deanfield J; Deloukas P; Dudbridge F; Fitzpatrick N; Gigante B; James S; Lokki ML; Lotufo PA; Marziliano N; Mordi IR; Muhlestein JB; Newton Cheh C; Pitha J; Saely CH; Samman-Tahhan A; Sandesara PB; Teren A; Timmis A; Van de Werf F; Wauters E; Wilde AAM; Ford I; Stott DJ; Algra A; Andreassi MG; Ardissino D; Arsenault BJ; Ballantyne CM; Bergmeijer TO; Bezzina CR; Body SC; Bogaty P; de Borst GJ; Brenner H; Burkhardt R; Carpeggiani C; Condorelli G; Cooper-DeHoff RM; Cresci S; de Faire U; Doughty RN; Drexel H; Engert JC; Fox KAA; Girelli D; Hagström E; Hazen SL; Held C; Hemingway H; Hoefer IE; Hovingh GK; Johnson JA; de Jong PA; Jukema JW; Kaczor MP; Kähönen M; Kettner J; Kiliszek M; Klungel OH; Lagerqvist B; Lambrechts D; Laurikka JO; Lehtimäki T; Lindholm D; Mahmoodi BK; Maitland-van der Zee AH; McPherson R; Melander O; Metspalu A; Pepinski W; Olivieri O; Opolski G; Palmer CN; Pasterkamp G; Pepine CJ; Pereira AC; Pilote L; Quyyumi AA; Richards AM; Sanak M; Scholz M; Siegbahn A; Sinisalo J; Smith JG; Spertus JA; Stewart AFR; Szczeklik W; Szpakowicz A; Ten Berg JM; Thanassoulis G; Thiery J; van der Graaf Y; Visseren FLJ; Waltenberger J; ; Van der Harst P; Tardif JC; Sattar N; Lang CC; Pare G; Brophy JM; Anderson JL; März W; Wallentin L; Cameron VA; Horne BD; Samani NJ; Hingorani AD; Asselbergs FW
Circ Genom Precis Med; 2019 Apr; 12(4):e002471. PubMed ID: 30897348
[TBL] [Abstract][Full Text] [Related]
4. Subsequent Event Risk in Individuals With Established Coronary Heart Disease.
Patel RS; Tragante V; Schmidt AF; McCubrey RO; Holmes MV; Howe LJ; Direk K; Åkerblom A; Leander K; Virani SS; Kaminski KA; Muehlschlegel JD; Allayee H; Almgren P; Alver M; Baranova EV; Behloui H; Boeckx B; Braund PS; Breitling LP; Delgado G; Duarte NE; Dubé MP; Dufresne L; Eriksson N; Foco L; Scholz M; Gijsberts CM; Glinge C; Gong Y; Hartiala J; Heydarpour M; Hubacek JA; Kleber M; Kofink D; Kotti S; Kuukasjärvi P; Lee VV; Leiherer A; Lenzini PA; Levin D; Lyytikäinen LP; Martinelli N; Mons U; Nelson CP; Nikus K; Pilbrow AP; Ploski R; Sun YV; Tanck MWT; Tang WHW; Trompet S; van der Laan SW; Van Setten J; Vilmundarson RO; Viviani Anselmi C; Vlachopoulou E; Al Ali L; Boerwinkle E; Briguori C; Carlquist JF; Carruthers KF; Casu G; Deanfield J; Deloukas P; Dudbridge F; Engstrøm T; Fitzpatrick N; Fox K; Gigante B; James S; Lokki ML; Lotufo PA; Marziliano N; Mordi IR; Muhlestein JB; Newton-Cheh C; Pitha J; Saely CH; Samman-Tahhan A; Sandesara PB; Teren A; Timmis A; Van de Werf F; Wauters E; Wilde AAM; Ford I; Stott DJ; Algra A; Andreassi MG; Ardissino D; Arsenault BJ; Ballantyne CM; Bergmeijer TO; Bezzina CR; Body SC; Boersma EH; Bogaty P; Bots ML; Brenner H; Brugts JJ; Burkhardt R; Carpeggiani C; Condorelli G; Cooper-DeHoff RM; Cresci S; Danchin N; de Faire U; Doughty RN; Drexel H; Engert JC; Fox KAA; Girelli D; Grobbee DE; Hagström E; Hazen SL; Held C; Hemingway H; Hoefer IE; Hovingh GK; Jabbari R; Johnson JA; Jukema JW; Kaczor MP; Kähönen M; Kettner J; Kiliszek M; Klungel OH; Lagerqvist B; Lambrechts D; Laurikka JO; Lehtimäki T; Lindholm D; Mahmoodi BK; Maitland-van der Zee AH; McPherson R; Melander O; Metspalu A; Niemcunowicz-Janica A; Olivieri O; Opolski G; Palmer CN; Pasterkamp G; Pepine CJ; Pereira AC; Pilote L; Quyyumi AA; Richards AM; Sanak M; Siegbahn A; Simon T; Sinisalo J; Smith JG; Spertus JA; Stender S; Stewart AFR; Szczeklik W; Szpakowicz A; Tardif JC; Ten Berg JM; Tfelt-Hansen J; Thanassoulis G; Thiery J; Torp-Pedersen C; van der Graaf Y; Visseren FLJ; Waltenberger J; Weeke PE; Van der Harst P; Lang CC; Sattar N; Cameron VA; Anderson JL; Brophy JM; Pare G; Horne BD; März W; Wallentin L; Samani NJ; Hingorani AD; Asselbergs FW
Circ Genom Precis Med; 2019 Apr; 12(4):e002470. PubMed ID: 30896328
[TBL] [Abstract][Full Text] [Related]
5. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.
ElFihry R; Elmessaoudi-Idrissi M; Jadid FZ; Zaidane I; Chihab H; Tahiri M; Kabine M; Badre W; Chemin I; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
Virol Sin; 2020 Oct; 35(5):566-574. PubMed ID: 32297157
[TBL] [Abstract][Full Text] [Related]
6. An exonic peroxisome proliferator-activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway.
Mirzaei K; Hossein-nezhad A; Emamgholipour S; Ansar H; Khosrofar M; Tootee A; Alatab S
J Nutrigenet Nutrigenomics; 2012; 5(2):59-71. PubMed ID: 22652814
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
[TBL] [Abstract][Full Text] [Related]
8. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
9. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
10. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
Yang Y; Mo X; Chen S; Lu X; Gu D
Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between
Du F; Yang KJ; Piao LS
Open Life Sci; 2019 Jan; 14():43-52. PubMed ID: 33817136
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses.
Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
Vasc Health Risk Manag; 2008; 4(2):427-36. PubMed ID: 18561518
[TBL] [Abstract][Full Text] [Related]
13. Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population.
Wu HH; Liu NJ; Yang Z; Tao XM; Du YP; Wang XC; Lu B; Zhang ZY; Hu RM; Wen J
Diabetol Metab Syndr; 2014; 6(1):107. PubMed ID: 25302081
[TBL] [Abstract][Full Text] [Related]
14. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
16. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
17. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study.
Brito EC; Vimaleswaran KS; Brage S; Andersen LB; Sardinha LB; Wareham NJ; Ekelund U; Loos RJ; Franks PW
Diabetologia; 2009 Apr; 52(4):609-13. PubMed ID: 19183932
[TBL] [Abstract][Full Text] [Related]
18. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
[TBL] [Abstract][Full Text] [Related]
19. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
[TBL] [Abstract][Full Text] [Related]
20. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI.
Povel CM; Feskens EJ; Imholz S; Blaak EE; Boer JM; Dollé ME
Int J Obes (Lond); 2010 May; 34(5):840-5. PubMed ID: 20125101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
